An announcement from Sinopharm Group Co ( (HK:1099) ) is now available.
Sinopharm Group Co. Ltd. has announced a board meeting scheduled for March 21, 2025, to discuss and approve the annual results for the year ending December 31, 2024, and to consider the declaration of dividends. This meeting is significant as it will provide insights into the company’s financial performance and potential returns for shareholders, impacting its market positioning and stakeholder interests.
More about Sinopharm Group Co
Sinopharm Group Co. Ltd. is a joint stock limited company incorporated in the People’s Republic of China, operating in the healthcare industry. The company is primarily involved in the distribution of pharmaceutical and healthcare products and services, with a significant market presence in Hong Kong.
YTD Price Performance: -8.47%
Average Trading Volume: 866
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.88B
See more insights into 1099 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com